111 related articles for article (PubMed ID: 2024808)
1. Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma.
Driver AG; Kukoly CA; Metzger WJ; Mustafa SJ
Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1002-7. PubMed ID: 2024808
[TBL] [Abstract][Full Text] [Related]
2. Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic "fog" of distilled water in asthmatics.
Moscato G; Dellabianca A; Falagiani P; Mistrello G; Rossi G; Rampulla C
Am Rev Respir Dis; 1991 Mar; 143(3):561-6. PubMed ID: 2001067
[TBL] [Abstract][Full Text] [Related]
3. Serum neutrophil chemotactic activity (NCA) during aspirin-induced bronchoconstriction.
Grzelewska-Rzymowska I; Szmidt M; Rozniecki J; Grzegorczyk J
Allergol Immunopathol (Madr); 1988; 16(2):99-103. PubMed ID: 3293381
[TBL] [Abstract][Full Text] [Related]
4. Enhanced neutrophil chemotactic activity after bronchial challenge in subjects with grain dust-induced asthma.
Park HS; Jung KS
Ann Allergy Asthma Immunol; 1998 Mar; 80(3):257-62. PubMed ID: 9532975
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil chemotactic activity in toluene diisocyanate (TDI)-induced asthma.
Sastre J; Banks DE; Lopez M; Barkman HW; Salvaggio JE
J Allergy Clin Immunol; 1990 Mar; 85(3):567-72. PubMed ID: 2155957
[TBL] [Abstract][Full Text] [Related]
6. Enhanced serum neutrophil chemotactic activity was noted in both early and late asthmatic responses during lysine-aspirin bronchoprovocation test in ASA-sensitive asthmatic patients.
Kim SS; Park HS; Yoon HJ; Lee YM; Lee SK; Nahm DH
J Korean Med Sci; 2003 Feb; 18(1):42-7. PubMed ID: 12589085
[TBL] [Abstract][Full Text] [Related]
7. A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthma.
Belcher NG; Murdoch RD; Dalton N; House FR; Clark TJ; Rees PJ; Lee TH
Am Rev Respir Dis; 1988 May; 137(5):1026-32. PubMed ID: 3195802
[TBL] [Abstract][Full Text] [Related]
8. Mediators of hypersensitivity and "fog"-induced asthma.
Shaw RJ; Anderson SD; Durham SR; Taylor KM; Schoeffel RE; Green W; Torzillo P; Kay AB
Allergy; 1985 Jan; 40(1):48-57. PubMed ID: 2579599
[TBL] [Abstract][Full Text] [Related]
9. The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma.
Howarth PH; Durham SR; Kay AB; Holgate ST
J Allergy Clin Immunol; 1987 Nov; 80(5):703-11. PubMed ID: 2445803
[TBL] [Abstract][Full Text] [Related]
10. Effect of salbutamol and inhaled sodium cromoglycate on the airway and neutrophil chemotactic activity in "fog"induced bronchospasm.
Moscato G; Rampulla C; Dellabianca A; Zanotti E; Candura S
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):382-8. PubMed ID: 3139728
[TBL] [Abstract][Full Text] [Related]
11. [Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity].
Szmidt M; Grzelewska-Rzymowska I; Rozniecki J; Grzegorczyk J
Pneumonol Alergol Pol; 1991; 59(1-2):16-21. PubMed ID: 1843881
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum heat-stable neutrophil chemotactic activity during early airway reaction to allergen and the pattern of airway response (early versus late reactions) in asthmatic subjects.
Dente FL; Carnevali S; Paggiaro PL; Cianchetti S; Bacci E; Bancalari L; Di Franco A; Giannini D; Vagaggini B; Giuntini C
Respiration; 1997; 64(4):285-90. PubMed ID: 9257364
[TBL] [Abstract][Full Text] [Related]
13. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
[TBL] [Abstract][Full Text] [Related]
14. Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release.
Cushley MJ; Holgate ST
J Allergy Clin Immunol; 1985 Feb; 75(2):272-8. PubMed ID: 2981912
[TBL] [Abstract][Full Text] [Related]
15. The effect of RP 59227, a platelet-activating factor antagonist, against antigen challenge and eosinophil and neutrophil chemotaxis in asthmatics.
Townley RG; Eda R; Hopp RJ; Bewtra AK; Gillen MS
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):345-53. PubMed ID: 7812682
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil chemotactic activity in acute severe asthma (status asthmaticus).
Buchanan DR; Cromwell O; Kay AB
Am Rev Respir Dis; 1987 Dec; 136(6):1397-402. PubMed ID: 3688645
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of neutrophil chemotactic activity in aspirin-induced asthma.
Hollingsworth HM; Downing ET; Braman SS; Glassroth J; Binder R; Center DM
Am Rev Respir Dis; 1984 Sep; 130(3):373-9. PubMed ID: 6433757
[TBL] [Abstract][Full Text] [Related]
18. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.
Van Schoor J; Joos GF; Kips JC; Drajesk JF; Carpentier PJ; Pauwels RA
Am J Respir Crit Care Med; 1997 Mar; 155(3):875-80. PubMed ID: 9117020
[TBL] [Abstract][Full Text] [Related]
19. Cultured peripheral blood mononuclear cells derived from patients with acute severe asthma ("status asthmaticus") spontaneously elaborate a neutrophil chemotactic activity distinct from interleukin-8.
Corrigan CJ; Collard P; Nagy L; Kay AB
Am Rev Respir Dis; 1991 Mar; 143(3):538-44. PubMed ID: 2001064
[TBL] [Abstract][Full Text] [Related]
20. Effects of nedocromil sodium on bronchospasm and HS-NCA release induced by allergen inhalation in asthmatic patients.
Mirone C; Fontana A; Mosca S; Bosetti M; Sala A; Scibilia J; Ortolani C
Clin Exp Allergy; 1994 Mar; 24(3):281-7. PubMed ID: 8012860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
